The TyG index is a validated surrogate marker for hepatic and peripheral insulin resistance, which contributes to CKD pathogenesis through glomerular hyperfiltration, activation of the renin–angiotensin–aldosterone system, endothelial dysfunction, and pro-inflammatory and pro-fibrotic mechanisms [15,17,18]. This evidence concerns the gene REN and chronic kidney disease.